J. Paul Marcoux, II, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Small Cell Lung Carcinoma | 2 | 2020 | 388 | 0.250 |
Why?
|
| Lung Neoplasms | 8 | 2021 | 13104 | 0.180 |
Why?
|
| Hemolytic-Uremic Syndrome | 1 | 2000 | 110 | 0.180 |
Why?
|
| Salvage Therapy | 2 | 2020 | 1275 | 0.170 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 5 | 2021 | 5223 | 0.170 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2021 | 806 | 0.130 |
Why?
|
| Ticlopidine | 1 | 2000 | 899 | 0.120 |
Why?
|
| Drug Resistance, Neoplasm | 4 | 2020 | 5172 | 0.120 |
Why?
|
| Antineoplastic Agents | 4 | 2020 | 13693 | 0.100 |
Why?
|
| Physician Impairment | 1 | 1991 | 73 | 0.100 |
Why?
|
| Rhinitis, Allergic, Seasonal | 3 | 1988 | 99 | 0.100 |
Why?
|
| Cromolyn Sodium | 2 | 1988 | 87 | 0.090 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2020 | 9240 | 0.090 |
Why?
|
| Beclomethasone | 1 | 1987 | 38 | 0.070 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2000 | 3070 | 0.070 |
Why?
|
| Fluocinolone Acetonide | 1 | 1987 | 36 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2011 | 5534 | 0.060 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2011 | 1581 | 0.060 |
Why?
|
| Pneumonia | 1 | 2016 | 2133 | 0.060 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2011 | 1660 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 1213 | 0.060 |
Why?
|
| Family | 1 | 2013 | 3147 | 0.050 |
Why?
|
| Life Style | 1 | 2013 | 3835 | 0.050 |
Why?
|
| Health Behavior | 1 | 2013 | 2635 | 0.050 |
Why?
|
| Smoking Cessation | 1 | 2013 | 2071 | 0.050 |
Why?
|
| Health Promotion | 1 | 2013 | 2205 | 0.050 |
Why?
|
| Plasmapheresis | 1 | 2000 | 211 | 0.040 |
Why?
|
| Troleandomycin | 1 | 1978 | 2 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11525 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 2 | 2016 | 9274 | 0.040 |
Why?
|
| Maximum Tolerated Dose | 1 | 2020 | 892 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 3799 | 0.040 |
Why?
|
| Phthalazines | 1 | 2019 | 363 | 0.040 |
Why?
|
| Asthma | 5 | 1995 | 6010 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2020 | 2327 | 0.030 |
Why?
|
| Angina, Unstable | 1 | 2000 | 926 | 0.030 |
Why?
|
| Nedocromil | 1 | 1995 | 46 | 0.030 |
Why?
|
| Radiotherapy Dosage | 1 | 2021 | 2879 | 0.030 |
Why?
|
| Prednisolone | 1 | 2016 | 334 | 0.030 |
Why?
|
| Theophylline | 1 | 1995 | 132 | 0.030 |
Why?
|
| Bronchitis | 1 | 1995 | 200 | 0.030 |
Why?
|
| Albuterol | 1 | 1995 | 208 | 0.030 |
Why?
|
| Bronchial Hyperreactivity | 1 | 1995 | 319 | 0.030 |
Why?
|
| Aged | 9 | 2021 | 163288 | 0.030 |
Why?
|
| Angioedema | 2 | 1984 | 187 | 0.030 |
Why?
|
| Aged, 80 and over | 4 | 2020 | 57776 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 3554 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2021 | 6896 | 0.020 |
Why?
|
| Middle Aged | 12 | 2020 | 213390 | 0.020 |
Why?
|
| Liver Diseases | 1 | 1978 | 1253 | 0.020 |
Why?
|
| Mutation | 2 | 2011 | 29786 | 0.020 |
Why?
|
| Eosinophilia | 2 | 1984 | 541 | 0.020 |
Why?
|
| Pulmonary Emphysema | 1 | 1995 | 672 | 0.020 |
Why?
|
| Administration, Intranasal | 2 | 1988 | 446 | 0.020 |
Why?
|
| Piperazines | 1 | 2019 | 2488 | 0.020 |
Why?
|
| Neoplasm Staging | 2 | 2016 | 11031 | 0.020 |
Why?
|
| Laryngeal Edema | 1 | 1988 | 21 | 0.020 |
Why?
|
| Stents | 1 | 2000 | 3282 | 0.020 |
Why?
|
| Male | 14 | 2020 | 350115 | 0.020 |
Why?
|
| Humans | 21 | 2021 | 744366 | 0.020 |
Why?
|
| Behavior Therapy | 1 | 2013 | 865 | 0.020 |
Why?
|
| Computational Biology | 1 | 2019 | 3519 | 0.020 |
Why?
|
| Female | 14 | 2021 | 380193 | 0.020 |
Why?
|
| Risk Reduction Behavior | 1 | 2013 | 1125 | 0.020 |
Why?
|
| Pharyngitis | 1 | 1988 | 215 | 0.020 |
Why?
|
| Random Allocation | 2 | 1988 | 2428 | 0.020 |
Why?
|
| HIV Infections | 1 | 1991 | 16715 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2019 | 63107 | 0.020 |
Why?
|
| Remission Induction | 1 | 2010 | 2385 | 0.020 |
Why?
|
| Bronchial Provocation Tests | 2 | 1995 | 227 | 0.020 |
Why?
|
| Adult | 11 | 2020 | 214052 | 0.020 |
Why?
|
| Ribonucleases | 1 | 1984 | 287 | 0.010 |
Why?
|
| Cell Line, Tumor | 2 | 2011 | 16690 | 0.010 |
Why?
|
| Postoperative Care | 1 | 1969 | 1487 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2011 | 5451 | 0.010 |
Why?
|
| Pyrazoles | 1 | 2011 | 1972 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2013 | 3188 | 0.010 |
Why?
|
| Mast Cells | 1 | 1988 | 1544 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2013 | 8319 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 2 | 2016 | 7182 | 0.010 |
Why?
|
| Pyridines | 1 | 2011 | 2825 | 0.010 |
Why?
|
| Prognosis | 1 | 2020 | 29060 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 39052 | 0.010 |
Why?
|
| Receptor, erbB-2 | 1 | 2008 | 2417 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1988 | 1790 | 0.010 |
Why?
|
| Adolescent | 6 | 2013 | 85779 | 0.010 |
Why?
|
| Survival Rate | 1 | 2010 | 12788 | 0.010 |
Why?
|
| Methacholine Chloride | 1 | 1995 | 233 | 0.010 |
Why?
|
| Long-Term Care | 1 | 1978 | 607 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2021 | 77460 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2016 | 20130 | 0.010 |
Why?
|
| Mice | 1 | 2019 | 81201 | 0.010 |
Why?
|
| Administration, Inhalation | 1 | 1995 | 1105 | 0.010 |
Why?
|
| Apoptosis | 1 | 2008 | 9724 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 25039 | 0.010 |
Why?
|
| Bronchodilator Agents | 1 | 1995 | 502 | 0.010 |
Why?
|
| Delayed-Action Preparations | 1 | 1995 | 968 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 1987 | 7914 | 0.010 |
Why?
|
| Respiratory Function Tests | 1 | 1995 | 1617 | 0.010 |
Why?
|
| Nitrofurantoin | 1 | 1969 | 19 | 0.010 |
Why?
|
| Forced Expiratory Volume | 1 | 1995 | 1745 | 0.010 |
Why?
|
| Tranquilizing Agents | 1 | 1969 | 59 | 0.010 |
Why?
|
| Child | 5 | 1995 | 77709 | 0.010 |
Why?
|
| Glucocorticoids | 2 | 1988 | 2108 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 1995 | 2887 | 0.010 |
Why?
|
| Uvula | 1 | 1988 | 16 | 0.000 |
Why?
|
| Immunoglobulins | 1 | 1971 | 881 | 0.000 |
Why?
|
| Signal Transduction | 1 | 2011 | 23404 | 0.000 |
Why?
|
| Double-Blind Method | 2 | 1995 | 12025 | 0.000 |
Why?
|
| Animals | 1 | 2019 | 168768 | 0.000 |
Why?
|
| Drug Administration Schedule | 1 | 1995 | 4933 | 0.000 |
Why?
|
| Glottis | 1 | 1988 | 217 | 0.000 |
Why?
|
| Analysis of Variance | 1 | 1995 | 6366 | 0.000 |
Why?
|
| Hypertension, Portal | 1 | 1968 | 220 | 0.000 |
Why?
|
| Eosinophil Granule Proteins | 1 | 1984 | 30 | 0.000 |
Why?
|
| Serum Albumin | 1 | 1968 | 675 | 0.000 |
Why?
|
| Risk Factors | 1 | 1991 | 72296 | 0.000 |
Why?
|
| Airway Obstruction | 1 | 1988 | 664 | 0.000 |
Why?
|
| Hypnotics and Sedatives | 1 | 1969 | 1162 | 0.000 |
Why?
|
| Sulfonamides | 1 | 1969 | 1940 | 0.000 |
Why?
|
| Eosinophils | 1 | 1984 | 955 | 0.000 |
Why?
|
| Blood Proteins | 1 | 1984 | 1124 | 0.000 |
Why?
|
| Liver Cirrhosis | 1 | 1968 | 1862 | 0.000 |
Why?
|
| Antidepressive Agents | 1 | 1969 | 2838 | 0.000 |
Why?
|
| Recurrence | 1 | 1988 | 8340 | 0.000 |
Why?
|
| Body Weight | 1 | 1984 | 4671 | 0.000 |
Why?
|
| Time Factors | 1 | 1995 | 40075 | 0.000 |
Why?
|
| Myeloma Proteins | 1 | 1971 | 72 | 0.000 |
Why?
|
| Insect Bites and Stings | 1 | 1971 | 67 | 0.000 |
Why?
|
| Radioimmunoassay | 1 | 1971 | 919 | 0.000 |
Why?
|
| Skin | 1 | 1984 | 4372 | 0.000 |
Why?
|
| Urticaria | 1 | 1971 | 150 | 0.000 |
Why?
|
| Polyps | 1 | 1971 | 189 | 0.000 |
Why?
|
| Skin Tests | 1 | 1971 | 613 | 0.000 |
Why?
|
| Serum Albumin, Radio-Iodinated | 1 | 1968 | 37 | 0.000 |
Why?
|
| Hypoproteinemia | 1 | 1968 | 12 | 0.000 |
Why?
|
| Radioisotope Dilution Technique | 1 | 1968 | 70 | 0.000 |
Why?
|
| Povidone | 1 | 1968 | 33 | 0.000 |
Why?
|
| Immunoglobulin E | 1 | 1971 | 1463 | 0.000 |
Why?
|
| Food Hypersensitivity | 1 | 1971 | 622 | 0.000 |
Why?
|
| Drug Hypersensitivity | 1 | 1971 | 884 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1984 | 41005 | 0.000 |
Why?
|
| Aspirin | 1 | 1971 | 3283 | 0.000 |
Why?
|